AU
CA
NZ
UK
US
IND
Kalkine has a fully transformed New Avatar.
Last update at 2026-03-10T16:35:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | -15.10000M | -35.30000M | 11.30M | 11.20M | 22.00M |
| Minority interest | - | - | - | - | - |
| Net income | -11.50000M | -24.30000M | 13.40M | 6.50M | 12.00M |
| Selling general administrative | 168.40M | 148.80M | 156.60M | 158.60M | 154.90M |
| Selling and marketing expenses | 77.90M | 64.30M | 56.00M | 57.30M | 56.60M |
| Gross profit | 263.60M | 190.80M | 237.00M | 243.20M | 240.40M |
| Reconciled depreciation | 23.00M | 23.50M | 23.80M | 22.90M | 20.30M |
| Ebit | 3.80M | -27.30000M | 23.60M | 26.20M | 26.60M |
| Ebitda | 26.80M | -3.80000M | 47.40M | 49.10M | 47.30M |
| Depreciation and amortization | 23.00M | 23.50M | 23.80M | 22.90M | 20.70M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 10.30M | -26.70000M | 15.50M | 15.40M | 26.60M |
| Other operating expenses | 871.70M | 700.60M | 657.90M | 678.90M | 694.30M |
| Interest expense | 11.90M | 3.60M | 3.40M | 3.50M | 4.60M |
| Tax provision | -3.60000M | -11.30000M | -2.70000M | 4.50M | 10.00M |
| Interest income | - | - | 2.80M | 2.50M | 2.80M |
| Net interest income | -25.60000M | -8.20000M | -4.40000M | -4.40000M | -4.20000M |
| Extraordinary items | - | - | -0.60000M | -0.20000M | -3.90000M |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | -3.60000M | -11.30000M | -2.70000M | 4.50M | 10.00M |
| Total revenue | 889.00M | 678.30M | 682.30M | 706.20M | 721.30M |
| Total operating expenses | 246.30M | 213.10M | 212.60M | 215.90M | 213.40M |
| Cost of revenue | 625.40M | 487.50M | 445.30M | 463.00M | 480.90M |
| Total other income expense net | -26.00000M | -4.20000M | -10.40000M | -15.50000M | -4.60000M |
| Discontinued operations | - | -0.30000M | -0.60000M | -0.20000M | -3.90000M |
| Net income from continuing ops | -11.50000M | -24.00000M | 14.00M | 6.70M | 12.00M |
| Net income applicable to common shares | -11.50000M | -24.30000M | 13.40M | 6.50M | 8.10M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Total assets | 470.30M | 466.10M | 431.80M | 471.80M | 435.10M |
| Intangible assets | 6.50M | 7.30M | 8.10M | 8.50M | 9.10M |
| Earning assets | - | - | - | - | - |
| Other current assets | 149.90M | 149.90M | 123.40M | 145.90M | 148.60M |
| Total liab | 433.20M | 409.10M | 362.00M | 404.90M | 370.90M |
| Total stockholder equity | 37.10M | 57.00M | 69.80M | 66.90M | 64.20M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 120.90M | 119.60M | 102.70M | 105.10M | 11.40M |
| Common stock | 17.40M | 17.40M | 17.40M | 18.30M | 18.30M |
| Capital stock | 17.40M | 17.40M | 17.40M | 18.30M | 18.30M |
| Retained earnings | -127.80000M | -106.20000M | -92.20000M | -96.60000M | -97.90000M |
| Other liab | 34.30M | 24.60M | 42.30M | 42.00M | 41.90M |
| Good will | 19.70M | 19.70M | 19.70M | 19.90M | 20.40M |
| Other assets | 46.10M | 31.60M | 22.90M | 20.60M | 17.50M |
| Cash | 1.60M | 4.50M | 24.90M | 44.20M | 14.40M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 283.60M | 280.00M | 233.50M | 253.90M | 237.20M |
| Current deferred revenue | -109.70000M | -110.90000M | -95.50000M | -86.00000M | - |
| Net debt | 166.50M | 164.40M | 118.40M | 101.50M | 120.90M |
| Short term debt | 52.80M | 64.40M | 57.10M | 36.70M | 43.50M |
| Short long term debt | 49.30M | 60.50M | 53.70M | 33.20M | 43.50M |
| Short long term debt total | 168.10M | 168.90M | 143.30M | 145.70M | 135.30M |
| Other stockholder equity | 110.40M | 88.80M | 74.80M | 78.30M | 143.80M |
| Property plant equipment | 126.30M | 134.20M | 139.80M | 135.20M | 130.10M |
| Total current assets | 271.70M | 273.30M | 241.20M | 287.60M | 258.00M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | 10.90M | 30.00M | 41.90M | 38.50M | 34.70M |
| Short term investments | - | - | - | - | - |
| Net receivables | 145.70M | 149.30M | 121.60M | 141.20M | 145.60M |
| Long term debt | 109.80M | 96.40M | 78.30M | 103.80M | 91.80M |
| Inventory | 121.50M | 118.90M | 92.90M | 97.50M | 95.00M |
| Accounts payable | 219.60M | 206.90M | 169.20M | 198.10M | 182.30M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | -368.40000M | -390.70000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | 17.40M | 18.30M | 18.30M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | -152.50000M | 0.10M | 0.10M | -163.60000M | 0.60M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 198.60M | 192.80M | 190.60M | 184.20M | 177.10M |
| Capital lease obligations | 9.00M | 12.00M | 11.30M | 8.70M | 0.00000M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | -11.60000M | -7.80000M | -19.80000M | -15.30000M | -4.60000M |
| Change to liabilities | 11.10M | 37.80M | -22.20000M | 12.80M | -20.90000M |
| Total cashflows from investing activities | -11.60000M | -7.80000M | -19.80000M | -15.30000M | -4.60000M |
| Net borrowings | -1.70000M | 19.70M | -3.80000M | -4.60000M | 8.70M |
| Total cash from financing activities | -1.70000M | 17.70M | -12.90000M | -8.10000M | 0.10M |
| Change to operating activities | - | -27.40000M | -27.40000M | -27.40000M | -12.80000M |
| Net income | -15.10000M | -35.70000M | 10.60M | 10.90M | 16.20M |
| Change in cash | -2.90000M | -20.40000M | -19.30000M | 29.80M | 2.70M |
| Begin period cash flow | 4.50M | 24.90M | 44.20M | 14.40M | 11.70M |
| End period cash flow | 1.60M | 4.50M | 24.90M | 44.20M | 14.40M |
| Total cash from operating activities | 11.10M | -30.20000M | 14.60M | 51.70M | 7.30M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 23.00M | 23.50M | 23.80M | 22.90M | 20.30M |
| Other cashflows from investing activities | 0.40M | 0.40M | 3.80M | 0.60M | -0.80000M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | -2.70000M | -25.70000M | -0.40000M | -1.30000M | -3.60000M |
| Change to account receivables | -1.30000M | -27.40000M | 13.20M | 8.60M | 8.10M |
| Sale purchase of stock | -0.20000M | -0.20000M | -9.10000M | -3.50000M | -8.60000M |
| Other cashflows from financing activities | 3.40M | 121.70M | 100.00M | 5.60M | 8.70M |
| Change to netincome | -8.00000M | -14.10000M | -13.60000M | 1.80M | -5.20000M |
| Capital expenditures | 12.00M | 14.30M | 23.80M | 19.20M | 18.70M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 7.10M | -15.30000M | -9.40000M | 20.10M | -16.40000M |
| Stock based compensation | 0.50M | 0.30M | 0.30M | 0.40M | -0.20000M |
| Other non cash items | 26.40M | 8.20M | 11.10M | 13.10M | 10.00M |
| Free cash flow | -0.90000M | -44.50000M | -9.20000M | 32.50M | -11.40000M |
Sector: Consumer Defensive Industry: Household & Personal Products
| Company | Change (GBX) | Price (GBX) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MCB McBride plc |
- -% | 146.60 | - | 5.85 | 0.16 | 4.16 | 0.36 | 16.20 |
| ULVR Unilever PLC |
- -% | 4907.00 | 13.43 | 15.55 | 1.56 | 5.66 | 1.87 | 8.08 |
| RKT Reckitt Benckiser Group PLC |
- -% | 5482.00 | 17.55 | 15.29 | 2.58 | 4.22 | 3.09 | 11.89 |
| PZC PZ Cussons PLC |
- -% | 78.00 | 16.93 | - | 1.01 | 1.68 | 1.02 | 7.20 |
| W7L Warpaint London PLC |
4.00 1.82% | 224.00 | 32.95 | - | 3.81 | 6.31 | 3.56 | 19.81 |
McBride plc, together with its subsidiaries, manufactures and sells private label household and personal care products to retailers and brand owners in the United Kingdom, Germany, France, Australia, rest of Europe, rest of Asia-Pacific, and internationally. The company operates through five segments: Liquids, Powders, Unit dosing, Aerosols, and Asia Pacific. The Liquids segment offers laundry detergents, dishwasher liquids, and surface cleaners, as well as fabric conditioner, bleach, and toilet cleaners. The Unit dosing segment provides auto dishwasher tablets, laundry capsules, and water softeners. The Powders segment offers laundry, auto dishwashes, stain removers, and water softeners. The Aerosols segment provides household, personal care, insecticides, sanitizers, and professional cleaning products. The Asia Pacific segment offers hand/bodywash and hair care products, skin care products, auto dishwasher tablets, and laundry liquids. It offers products under the Surcare, Oven Pride, Clean N Fresh, Hospec, and Actiff brands. The company was founded in 1927 and is based in Manchester, the United Kingdom.
Middleton Way, Manchester, United Kingdom, M24 4DP
| Name | Title | Year Born |
|---|---|---|
| Mr. Christopher Ian Charles Smith | CEO & Exec. Director | 1964 |
| Mr. Mark Strickland | CFO & Director | NA |
| Ms. Glenda MacGeekie | Chief Legal Officer & Company Sec. | NA |
| Mr. Matthias Kreysel | Chief R&D Officer | NA |
| Mr. Peter Ingelse | Managing Director of Liquids | NA |
| Mr. Lennard Markestein | Managing Director of Unit Dosing | NA |
| Teong Dee Ong | Managing Director of Asia Pacific | NA |
| Marc Marot | Managing Director of Aerosols | NA |
| Marielle Claudon | Managing Director of Powders | NA |
| Mr. David Thomas Rattigan | Interim Director of Fin. & Group Financial Controller | 1970 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...